We are conducting a study on canine mast cell tumors to evaluate their cells and their response to specific chemotherapy drugs.
Currently Enrolling (Last Update: Oct 2024)
ImpriMed is actively conducting research on canine mast cell tumors (MCT). With your help, we can develop new precision oncology solutions to help you optimize treatment of this disease.
benefits to clinic
We are requesting the samples from:
Canine patients with suspected mast cell tumors
For each patient, we request all of the following:
If you have not already, please register for access to our Vet Portal by clicking HERE. To submit sample information, go to ‘Sample Submission’ > Canine Services, and select 'Canine MCT Pilot Study'
Please ensure all participating pet owners sign the consent form to allow us to use their dog’s sample for research.
To get started, fill out the form and we will send you our proprietary transport media tubes to your clinic.